Skip to content

Suzel Vazquez, MD

NPI 1407976145ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· South Miami, FL

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in South Miami, Florida, licensed in FL, with an NPI issued in March 2007. Part D covered 613 prescriptions written in 2024, 71% of them generic. Novo Nordisk Inc was the largest of 5 companies reporting payments in 2025, $205.41 in all, mostly food and beverage.

Overview

NPI1407976145
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 29, 2007
Last updated in NPPESFeb 19, 2010

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Endocrinology (FL)

Part D prescriptions in 2024

Prescriptions (claims)613 · 1,258 30-day fills
Patients66
Total drug cost$111,005
Generic share71% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$205.41 · 5 payments from 5 companies
  • 2024$34.40 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$114.901
Exact Sciences Corporation$24.341
Ibsa Pharma Inc.$23.921
Dexcom, Inc.$23.801
Lilly USA, LLC$18.451

What the 2025 payments were for

  • Food and Beverage$205.41 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in South Miami

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Florida →